127 related articles for article (PubMed ID: 6572541)
1. Treatment of erythroleukemia with anthracycline antibiotics and cytosine arabinoside.
Tamura K; Preisler HD
Cancer; 1983 May; 51(10):1795-9. PubMed ID: 6572541
[TBL] [Abstract][Full Text] [Related]
2. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
Early AP; Preisler HD; Gottlieb AJ; Lanchant NA
Br J Haematol; 1981 Jul; 48(3):369-75. PubMed ID: 7259987
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens.
Preisler HD; Rustum Y; Henderson ES; Bjornsson S; Creaven PJ; Higby DJ; Freeman A; Gailani S; Naeher C
Blood; 1979 Mar; 53(3):455-64. PubMed ID: 760861
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.
Preisler HD; Azarnia N; Raza A; Grunwald H; Vogler R; Browman G; Goldberg J; Chervenick P; Miller K; Brennan J
Br J Haematol; 1984 Mar; 56(3):399-407. PubMed ID: 6582925
[TBL] [Abstract][Full Text] [Related]
6. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
7. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
8. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
9. Epirubicin and cytosine arabinoside for the induction therapy of childhood acute nonlymphocytic leukemia.
Liang DC; Jiang CJ
Am J Hematol; 1991 Dec; 38(4):267-70. PubMed ID: 1746534
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
Uzuka Y; Liong SK; Yamagata S
Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159
[TBL] [Abstract][Full Text] [Related]
11. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.
Wolff SN; Marion J; Stein RS; Flexner JM; Lazarus HM; Spitzer TR; Phillips GL; Herzig RH; Herzig GP
Blood; 1985 Jun; 65(6):1407-11. PubMed ID: 3995177
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Cassileth PA; Katz ME
Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
[TBL] [Abstract][Full Text] [Related]
13. Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline.
Velu T; Debusscher L; Stryckmans P
Am J Hematol; 1988 Mar; 27(3):224-5. PubMed ID: 3162347
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
[TBL] [Abstract][Full Text] [Related]
15. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure.
Preisler HD; Reese PA; Marinello MJ; Pothier L
Br J Haematol; 1983 Mar; 53(3):459-66. PubMed ID: 6824587
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
Cassileth PA; Kahn SB; Silber R; Weiler C
Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
[TBL] [Abstract][Full Text] [Related]
19. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of the CFU-C assay in acute nonlymphocytic leukemia.
Kirshner JJ; Goldberg J; Nelson DA; Gottlieb AJ
Am J Med; 1982 Apr; 72(4):615-19. PubMed ID: 7041644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
